Osteoarthritis

Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.

Injection treatment of mild to moderate osteoarthritis of the knee or hip.
DUROLANE® has also been approved for the symptomatic treatment associated with mild to moderate osteoarthritis pain of the ankles, shoulders, elbows, wrists, fingers and toes.

Pain relief improves joint function and helps restore quality of life.

Arthrum HCS 40mg/2ml is indicated for all types of painful synovial joint arthritis, particularly gonarthrosis.

Arthrum HCS is biologically similar to human synovial fluid and participates in the following functions: Protect the cartilage, Protect the synovial membrane, Reduce pain and improve mobility

Indication: Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy related to joint alterations

Symptomatic treatment ofosteoarthritis.

Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.

SYNOVIUM HCS viscoelastic devices are indicated for the symptomatic treatment of gonarthrosis, in particular to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid in arthritic joints.

The therapeutic indications are all types of painful gonarthrosis:

- Primary gonarthrosis (Kelgreen radiological stages I, II and III)

- Gonarthrosis and associated general factors:

- Ineffectiveness of usual treatments.

- Intolerance and/or contraindication to NSAIDs and/or analgesics.

- Taking anticoagulants, poly-medication (hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems).

- Contraindications related to the fitting of a prosthesis: young patients and various contraindications related to the patient's condition.

- Early gonarthrosis in young patients.

- Gonarthrosis secondary to trauma and the aftermath of articular fractures.

COXARTHRUM is indicated to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid of the arthritic joint.

COXARTHRUM exerts its therapeutic effect by viscosupplementation, a process by which the physiological and rheological properties of the synovial fluid of the arthritic hip are improved.

COXARTHRUM is indicated for the symptomatic treatment of coxarthrosis by intra-articular injection. COXARTHRUM must be administered only intra-articularly under radio-guidance or by ultrasound and this by a specialist doctor, to relieve the pain associated with osteoarthritis of the hip.

OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.

Indication : Sinovial® One is indicated in case of pain or limitations of mobility due to degenerative or post-traumatic affections or to alterations of the joint and tendons, in order to restore the physiological and rheological conditions of arthrosic joints.

1 pre-filled syringe of 2.5ml 50MG/2.5 ML of hyaluronic acid

Indicated in the symptomatic treatment of osteoarthritis.

Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.

Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee

Description : This medication is recommended for painful osteoarthritis of the knee, with effusion.

Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee

Delayed-effect symptomatic treatment of osteoarthritis of the hip and knee.

Oral gel 1200 mg: Sachets, box of 30.

Indication : Medicine indicated in the symptomatic treatment of osteoarthritis in particular of the hip and the knee. Chondrosulf contains chondroitin sulphate and is indicated for adults (over 15 years).

Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.

Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee

Indications: Phytostandard of harpagophytum and willow Pileje is a food supplement to improve joint comfort.

The extracts of harpagophytum and willow are obtained through the patented Phytostandard® process known for its respect for the integrity of the plant's compounds.

Description: HYALEXO EXPANSCIENCE is a hyaluronic acid-based medical device indicated for the relief of pain in patients suffering fromosteoarthritis or degenerative joint diseases resulting in an alteration of the functional properties of synovial fluid.

Indications: STRUCTUM is used in adults (over 15 years of age) for the treatment of pain and functional discomfort in osteoarthritis of the knee and hip. This drug has a slow onset of action, delayed by about 2 months, and its effect may persist after treatment has been stopped.